Sea Crest Wealth Management, LLC Agenus Inc Transaction History

Sea Crest Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$2.53 - $3.04 $46,805 - $56,240	-18,500 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$2.51 - $3.73 $15,059 - $22,380	6,000 Added 48.0%	18,500 $55,000
Q4 2018 Feb 13, 2019	BUY	$1.59 - $2.66 $12,720 - $21,280	8,000 Added 177.78%	12,500 $30,000
Q3 2018 Nov 14, 2018	SELL	$1.59 - $2.42 $19,875 - $30,250	-12,500 Reduced 73.53%	4,500 $10,000
Q2 2018 Aug 03, 2018	SELL	$2.26 - $4.65 $37,290 - $76,725	-16,500 Reduced 49.25%	17,000 $39,000
Q1 2018 Apr 20, 2018	BUY	$3.51 - $6.04 $72,832 - $125,330	20,750 Added 162.75%	33,500 $158,000
Q4 2017 Feb 02, 2018	BUY	$3.26 - $4.78 $41,565 - $60,945	12,750	12,750 $42,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.